Word

AVONTEC

Status

Dead

Status Code

603

Status Date

Friday, May 13, 2005

Serial Number

76496366

Mark Type

1000

Filing Date

Monday, March 10, 2003

Abandoned Date

Friday, May 13, 2005

Trademark Owner History

AVONTEC GmbH

Classifications

1 Chemical preparations, namely buffer, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, additives, polypeptides for scientific purposes; chemical preparations for the investigation and characterization of diseases, namely, of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; nucleic acids for scientific purposes

5 Medicaments for the treatment of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; pharmaceutical and veterinary preparations for the control of the expression of genes relevant to said diseases; preparations for diagnosis and analysis of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; nucleic acids for medical, analytical and diagnostic purposes

35 Arranging and conducting business conferences

41 Educational services, namely offering seminars, workshops and symposiums in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; arranging educational conferences, and providing facilities for educational conventions

42 Scientific and industrial research and consulting, particularly in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; identification of target structures for the development of medicaments, particularly polypeptides and nucleic acids; research and development of new technologies and pharmaceutical products for others, particularly for the control of the expression of genes relevant to diseases; product and technology research and development for others, namely, development of processes and products for scientific and industrial research, particularly in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; product development in the field of nucleic acids

Trademark Events

May 23, 2005

Exparte Appeal Terminated

May 23, 2005

Abandonment Notice Mailed - After Ex Parte Appeal

May 13, 2005

Abandonment - After Ex Parte Appeal

May 13, 2005

Exparte Appeal Dsmsed - Failure To File Brief

Jan 10, 2005

Action Denying Req For Recon E-Mailed

Jan 10, 2005

Action Continuing Final - Completed

Oct 14, 2004

Ex Parte Appeal-Instituted

Oct 14, 2004

Jurisdiction Restored To Examining Attorney

Oct 13, 2004

Amendment From Applicant Entered

Sep 27, 2004

Correspondence Received In Law Office

Oct 12, 2004

Exparte Appeal Received At Ttab

Sep 27, 2004

Paper Received

May 10, 2004

Teas Change Of Correspondence Received

Mar 5, 2004

Unresponsive/Duplicate Paper Received

Mar 22, 2004

Final Refusal Mailed

Mar 5, 2004

Fax Received

Feb 23, 2004

Correspondence Received In Law Office

Feb 23, 2004

Teas Response To Office Action Received

Aug 25, 2003

Non-Final Action Mailed

Aug 25, 2003

Assigned To Examiner